CLINICAL_TRIALS
withdrawal
· 2016-03-31
Clinical Trial Update: Evaluation the Pharmacokinetics, Safety, Tolerability of BCD-021 in Patients With Neovascular Age-related Macular Degeneration [Phase 1]
Summary
A Phase 1 trial evaluating pharmacokinetics, safety, and tolerability of BCD-021 in patients with neovascular age-related macular degeneration has been withdraw…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biocad | Conditions: Neovascular Age-related Macular Degeneration | Phase 1 | Status: WITHDRAWN